← k3vl4r
Log inGet started →

CYTK (Cytokinetics Inc) Price Forecast

AI-generated price forecast for Cytokinetics Inc (CYTK) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads CYTK as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 51.32. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

51.32

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

CYTK forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-23.51%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called CYTK's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest CYTK news

From the market-news feed the forecasts are read against.

  • Cytokinetics Touts MYQORZO Launch Momentum, Plans New FDA Filing · Yahoo · Nov 17
  • Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Yahoo · Nov 16
  • Cytokinetics (NASDAQ:CYTK) Hits New 52-Week Low - Here's What Happened · ldr:marketbeat.com · Nov 16
  • Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM | CYTK Stock News · ldr:stocktitan.net · Nov 16
  • Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM · Yahoo · Nov 16

🔒

See the full CYTK forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

CYTK forecast — frequently asked

Will CYTK go up?

K3vl4r's calibrated AI forecast currently reads CYTK as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the CYTK price prediction for 2026?

K3vl4r's model projects CYTK toward $39.26 over the next ~4 weeks, a -23.5% move from $51.32. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

PRQRATYRSTVNKYTXEXELARQTNAMSERASCUPRAORTSGRYCOSMABCLACRV

Will CYTK reach…?

Will CYTK reach $100.00?Will CYTK reach $200.00?Will CYTK reach $250.00?

Or see the full CYTK price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare CYTK

CYTK vs PRQRCYTK vs ATYRCYTK vs STVNCYTK vs KYTXCYTK vs EXELCYTK vs ARQT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.